Last month’s announcement that the Bill and Melinda Gates Foundation will give up to $140 million to a Boston drug device manufacturer to develop an implantable mini-pump to deliver drugs for pre-exposure prophylaxis (PrEP) against HIV infection has focused attention on the future of PrEP. Is the future all about implants, or will it offer multiple options for people who want to use PrEP?
Community care teams in Australia will play an important part for ageing PLHIV diagnosed pre-1996.
The ACT Government announced, in August, that it will be supporting a PrEP trial for the ACT community. There will be 200 places offered on the trial and it is expected that enrolments will start early in the 2017
The lead agency in the ACT is Canberra Sexual Health Centre with significant support from ACT Health and NSW Health, the Kirby Institute, Interchange General Practice and the AIDS Action Council.
For more information or to add your name to the waiting list to find out more about the start of the trial please contact
Canberra Sexual Health Centre – 6244 2184
AIDS Action Council of the ACT – 6257 2855